Earnings Call · Q2 FY2026·2026-08-06

Q2 26EPS 0.00%·Rev n/aQ1 26EPS +100.00%*·Rev n/aQ4 25EPS -22.22%·Rev n/aQ3 25EPS +5.88%·Rev n/a⚠ consensus missing

Nuvation Bio Inc. NUVB

J.R. DeVita — Vice President, Corporate Development and Investor Relations

Dr. David Hung — Founder, President, and Chief Executive Officer

Colleen Sjogren — Chief Commercial Officer

Philippe Sauvage — Chief Financial Officer

−4.1%1d on move date3d+3.6%5d+0.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NUVB calls or request research access.

More NUVB calls Browse calls Request research access